2024 |
Do not forget mpox! |
Lettera |
Vai |
2023 |
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination |
Articolo in rivista |
Vai |
2023 |
Atypical case of monkeypox with multiple bacterial skin superinfection |
Articolo in rivista |
Vai |
2023 |
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2 |
Articolo in rivista |
Vai |
2023 |
Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy |
Articolo in rivista |
Vai |
2022 |
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France |
Articolo in rivista |
Vai |
2022 |
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination |
Articolo in rivista |
Vai |
2022 |
Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization |
Articolo in rivista |
Vai |
2021 |
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
Articolo in rivista |
Vai |
2021 |
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy |
Articolo in rivista |
Vai |
2021 |
Evaluation of the diagnostic performances of two commercially available assays for the detection of enteric adenovirus antigens |
Articolo in rivista |
Vai |
2021 |
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients |
Articolo in rivista |
Vai |
2020 |
Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition |
Articolo in rivista |
Vai |
2019 |
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) |
Articolo in rivista |
Vai |
2018 |
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals |
Articolo in rivista |
Vai |
2017 |
Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy |
Articolo in rivista |
Vai |
2016 |
Characterization of measles virus strains circulating in Southern Italy (Palermo area, Sicily) between 2010 and 2011 |
Articolo in rivista |
Vai |
2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
2015 |
Impact of HBV genotypes A and D genetic variability on infection evolution |
Articolo in rivista |
Vai |
2014 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene |
Abstract in rivista |
Vai |
2014 |
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors |
Articolo in rivista |
Vai |
2013 |
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance |
Articolo in rivista |
Vai |
2013 |
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients |
Articolo in rivista |
Vai |
2013 |
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis |
Abstract in rivista |
Vai |
2013 |
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. |
Articolo in rivista |
Vai |
2013 |
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC |
Abstract in rivista |
Vai |
2013 |
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. |
Articolo in rivista |
Vai |
2012 |
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. |
Articolo in rivista |
Vai |
2012 |
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV |
Abstract in rivista |
Vai |
2012 |
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. |
Articolo in rivista |
Vai |
2011 |
Liver follicular helper T-cells in chronic hepatitis C |
Abstract in rivista |
Vai |
2011 |
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. |
Articolo in rivista |
Vai |
2011 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
2011 |
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
2011 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
2011 |
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE |
Abstract in rivista |
Vai |
2010 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
2010 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
2010 |
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? |
Abstract in rivista |
Vai |
2009 |
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
2009 |
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
2009 |
HCV genotypes in Sicily: is there any evidence of a shift? |
Articolo in rivista |
Vai |
2009 |
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
2009 |
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. |
Articolo in rivista |
Vai |
2009 |
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE |
Abstract in rivista |
Vai |
2009 |
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? |
Articolo in rivista |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. |
Articolo in rivista |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C |
Articolo in rivista |
Vai |
2008 |
Genotyping of Legionella pneumophila serogroup 1 strains isolated in Northern Sicily, Italy. |
Articolo in rivista |
Vai |
2008 |
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay |
Articolo in rivista |
Vai |
2008 |
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The
Camporeale Model |
Articolo in rivista |
Vai |
2008 |
HCV genotypes in western Sicily: any evidence for a shift? |
Proceedings |
Vai |
2007 |
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS |
Proceedings |
Vai |
2007 |
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial |
Articolo in rivista |
Vai |
2007 |
INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE |
Proceedings |
Vai |
2007 |
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2007 |
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier |
Proceedings |
Vai |
2007 |
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
2007 |
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
2007 |
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale |
Proceedings |
Vai |
2006 |
RIATTIVAZIONE DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITÀ VIRALE |
Proceedings |
Vai |
2006 |
Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: the Camporeale model |
Proceedings |
Vai |
2006 |
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale |
Proceedings |
Vai |
2006 |
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. |
Articolo in rivista |
Vai |
2006 |
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial |
Articolo in rivista |
Vai |
2006 |
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C |
Articolo in rivista |
Vai |
2005 |
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir |
Proceedings |
Vai |
2005 |
RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO |
Proceedings |
Vai |
2005 |
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano |
Proceedings |
Vai |
2005 |
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings |
Vai |
2005 |
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings |
Vai |
2005 |
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy |
Articolo in rivista |
Vai |
2005 |
Hepatitis B virus reactivation and
alemtuzumab therapy |
Articolo in rivista |
Vai |
2005 |
Infezione occulta da HBV in pazienti con malattie oncoematologiche |
Proceedings |
Vai |
2004 |
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin |
Articolo in rivista |
Vai |
2004 |
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico |
Proceedings |
Vai |
2004 |
Hepatitis B virus reactivation and alemtuzumab therapy |
Proceedings |
Vai |
2003 |
IL-10 and TNF-α polymorphisms and the recovery from HCV infection |
Articolo in rivista |
Vai |
2003 |
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV |
Articolo in rivista |
Vai |
2003 |
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin |
Articolo in rivista |
Vai |
2003 |
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C |
Articolo in rivista |
Vai |
2002 |
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission |
Articolo in rivista |
Vai |
2002 |
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis |
Articolo in rivista |
Vai |
2002 |
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction |
Articolo in rivista |
Vai |
1990 |
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium |
Articolo in rivista |
Vai |
1990 |
Triiodothyronine accelerates the synthesis of Synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium |
Articolo in rivista |
Vai |
1987 |
Triiodothyronine‐Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium |
Articolo in rivista |
Vai |
1987 |
Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis |
Articolo in rivista |
Vai |
1986 |
Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis |
Articolo in rivista |
Vai |